We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Targeting RAS signalling pathways in cancer therapy.
- Authors
Downward, Julian
- Abstract
The RAS proteins control signalling pathways that are key regulators of several aspects of normal cell growth and malignant transformation. They are aberrant in most human tumours due to activating mutations in the RAS genes themselves or to alterations in upstream or downstream signalling components. Rational therapies that target the RAS pathways might inhibit tumour growth, survival and spread. Several of these new therapeutic agents are showing promise in the clinic and many more are being developed.
- Publication
Nature reviews. Cancer, 2003, Vol 3, Issue 1, p11
- ISSN
1474-175X
- Publication type
Journal Article
- DOI
10.1038/nrc969